The olfactory vector hypothesis of neurodegenerative disease: Is it viable?

Annals of Neurology

Volumn 63, Issue 1, 2008, Pages 7-15

  Doty, Richard L ^a  

^a UNIVERSITY OF PENNSYLVANIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

1,2,3,6 TETRAHYDRO 1 METHYL 4 PHENYLPYRIDINE; ALTROPANE; ALUMINUM LACTATE; ALUMINUM SILICATE; CADMIUM; CADMIUM CHLORIDE; CADMIUM OXIDE; COBALT; CYTOCHROME P450 2D6; GOLD; IRON OXIDE; LEUCINE RICH REPEAT KINASE 2; MANGANESE; MERCURY; METAL; NICKEL; SUPEROXIDE DISMUTASE; TOXIN; XENOBIOTIC AGENT; ZINC;

ALZHEIMER DISEASE; BLOOD BRAIN BARRIER; BLOOD NERVE BARRIER; CELL LOSS; CREUTZFELDT JAKOB DISEASE; DEGENERATIVE DISEASE; ENVIRONMENTAL FACTOR; HUMAN; NERVE FIBER TRANSECTION; NEUROPATHOLOGY; NONHUMAN; OLFACTORY EPITHELIUM; OLFACTORY RECEPTOR; OLFACTORY SYSTEM; PARKINSON DISEASE; PRION; PRIORITY JOURNAL; RAT; REVIEW; SINGLE PHOTON EMISSION COMPUTER TOMOGRAPHY; SMELLING; VIRUS;

ALZHEIMER DISEASE; ANIMALS; AXONAL TRANSPORT; DISEASE PROGRESSION; DYSKINESIA, DRUG-INDUCED; HAZARDOUS SUBSTANCES; HUMANS; NEURODEGENERATIVE DISEASES; OLFACTION DISORDERS; OLFACTORY MUCOSA; PARKINSON DISEASE; VIRUS DISEASES;

EID: 39049153943     PISSN: 03645134     EISSN: None     Source Type: Journal    
DOI: 10.1002/ana.21327     Document Type: Review

References (111)

1. Brown RC, Lockwood AH, Sonawane BR. Neurodegenerative diseases: an overview of environmental risk factors. Environ Health Perspect 2005;113:1250-1256.
2. Doty RL, Perl DP, Steele JC, et al. Odor identification deficit of the parkinsonism-dementia complex of Guam: equivalence to that of Alzheimer's and idiopathic Parkinson's disease. Neurology 1991;41:77-80.
3. Leverenz J, Sumi SM. Parkinsons disease in patients with Alzheimer's disease. Arch Neurol 1986;43:662-664.
4. Doty RL. Odor perception in neurodegenerative diseases. In: Doty RL, ed. Handbook of olfaction and gustation. 2nd ed. New York: Marcel Dekker, 2003:479-502.
5. Calderon-Garciduenas L, Reed W, Maronpot RR, et al. Brain inflammation and Alzheimer's-like pathology in individuals exposed to severe air pollution. Toxicol Pathol 2004;32:650-658.
6. Semchuk KM, Love EJ, Lee RG. Parkinsons disease and exposure to agricultural work and pesticide chemicals. Neurology 1992;42:1328-1335.
7. Gorell JM, Johnson CC, Rybicki BA, et al. Occupational exposure to manganese, copper, lead, iron, mercury and zinc and the risk of Parkinson's disease. Neurotoxicology 1999;20:239-247.
8. Perl DP, Olanow CW. The neuropathology of manganese-induced parkinsonism. J Neuropathol Exp Neurol 2007;66:675-682.
9. Ferreyra-Moyano H, Barragan E. The olfactory system and Alzheimer's disease. Int J Neurosci 1989;49:157-197.
10. Roberts E. Alzheimer's disease may begin in the nose and may be caused by aluminosilicates. Neurobiol Aging 1986;7:561-567.
11. Doty RL, Reyes PF, Gregor T. Presence of both odor identification and detection deficits in Alzheimer's disease. Brain Res Bull 1987;18:597-600.
12. Hawkes CH, Shephard BC, Daniel SE. Is Parkinson's disease a primary olfactory disorder? QJM 1999;92:473-480.
13. Doty RL. Cranial nerve I: olfaction. In: Goltz CG, Pappert EJ, eds. Textbook of clinical neurology. Philadelphia: WB Saunders, 1998:90-101.
14. Ding X, Dahl AR. Olfactory mucosa: composition, enzymatic localization, and metabolism. In: Doty RL, ed. Handbook of olfaction and gustation. 2nd ed. New York: Marcel Dekker, 2003:51-73.
15. Baker H, Genter MB. The olfactory system and the nasal mucosa as portals of entry of viruses, drugs, and other exogenous agents into the brain. In: Doty RL, ed. Handbook of olfaction and gustation. New York: Marcel Dekker, 2003:549-573.
16. Wright J. A history of laryngology and rhinology. Philadelphia: Lea & Febiger, 1914.
17. Flexner S, Clark PF. A note on the mode of infection in epidemic poliomyelitis. Proc Soc Expl Biol Med 1912;10:1-2.
18. Brodie M, Elvidge AR. The portal of entry and transmission of the virus of poliomyelitis. Science 1934;79:235-236.
19. Schultz EW, Gebhardt LP. Prevention of intranasally inoculated poliomyelitis in monkeys by previous intranasal irrigation with chemical agents. Proc Soc Exp Biol Med 1936;34:133-135.
20. Sabin AB. Olfactory bulbs in human poliomyelitis. Am J Dis Child 1940;60:1313-1318.
21. Sabin AB, Olitsky PK. Influence of pathway of infection on pathology of olfactory bulbs in experimental poliomyelitis. Proc Soc Exp Biol Med 1936;35:300-301.
22. Tisdall FF, Brown A, Defries RD, et al. Zinc-sulphate nasal spray in the prophylaxis of poliomyelitis. Can Pub Health J 1937;28:523-543.
23. Johnson RT, Mims CA. Pathogenesis of viral infections of the nervous system. N Engl J Med 1968;278:23-30, 84-92.
24. Monath TP, Croop CB, Harrison AK. Mode of entry of a neurotropic virus into the central nervous system: reinvestigation of an old controversy. Lab Invest 1983;48:399-410.
25. McLean JH, Shipley MT, Bernstein DI, et al. Selective lesions of neural pathways following viral inoculation of the olfactory bulb. Exp Neurol 1993;122:209-222.
26. Tjalve H, Henriksson J. Uptake of metals in the brain via olfactory pathways. Neurotoxicology 1999;20:181-195.
27. Henriksson J, Tjalve H. Manganese taken up into the CNS via the olfactory pathway in rats affects astrocytes. Toxicol Sci 2000;55:392-398.
28. Gillner M, Brittebo EB, Brandt I, et al. Uptake and specific binding of 2,3,7,8-tetrachlorodibenzo-p-dioxin in the olfactory mucosa of mice and rats. Cancer Res 1987;47:4150-4159.
29. Kamel F, Hoppin JA. Association of pesticide exposure with neurologic dysfunction and disease. Environ Health Perspect 2004;112:950-958.
30. Mancuso M, Giovanetti A, Brittebo EB. Effects of dichlobenil on ultrastructural morphology and cell replication in the mouse olfactory mucosa. Toxicol Pathol 1997;25:186-194.
31. Zanusso G, Ferrari S, Cardone F, et al. Detection of pathologic prion protein in the olfactory epithelium in sporadic Creutzfeldt-Jakob disease. N Engl J Med 2003;348:711-719.
32. Reuber M, Al-Din ASN, Baborie A, et al. New variant Creutzfeldt-Jakob disease presenting with loss of taste and smell. J Neurol Neurosurg Psychiatry 2001;71:412-413.
33. Baker H, Spencer RF. Transneuronal transport of peroxidase-conjugated wheat germ agglutinin (WGA-HRP) from the olfactory epithelium to the brain of the adult rat. Exp Brain Res 1986;63:461-473.
34. Doty RL, Deems DA, Stellar S. Olfactory dysfunction in parkinsonism: a general deficit unrelated to neurologic signs, disease stage, or disease duration. Neurology 1988;38:1237-1244.
35. Graves AB, Bowen JD, Rajaram L, et al. Impaired olfaction as a marker for cognitive decline: interaction with apolipoprotein E epsilon4 status. Neurology 1999;53:1480-1487.
36. Ponsen MM, Stoffers D, Booij J, et al. Idiopathic hyposmia as a preclinical sign of Parkinson's disease. Ann Neurol 2004;56:173-181.
37. Pearce RK, Hawkes CH, Daniel SE. The anterior olfactory nucleus in Parkinson's disease. Mov Disord 1995;10:283-287.
38. Ohm TG, Braak H. Olfactory bulb changes in Alzheimer's disease. Acta Neuropathol 1987;73:365-369.
39. Attems J, Jellinger KA. Olfactory tau pathology in Alzheimer disease and mild cognitive impairment. Clin Neuropathol 2006;25:265-271.
40. Kovacs T, Cairns NJ, Lantos PL. Olfactory centres in Alzheimer's disease: olfactory bulb is involved in early Braak's stages. Neuroreport 2001;12:285-288.
41. Kulkarni-Narla A, Getchell TV, Schmitt FA, et al. Manganese and copper-zinc superoxide dismutases in the human olfactory mucosa: increased immunoreactivity in Alzheimer's disease. Exp Neurol 1996;140:115-125.
42. Perry G, Castellani RJ, Smith MA, et al. Oxidative damage in the olfactory system in Alzheimer's disease. Acta Neuropathol 2003;106:552-556.
43. Braak H, Rub U, Gai WP, et al. Idiopathic Parkinson's disease: possible routes by which vulnerable neuronal types may be subject to neuroinvasion by an unknown pathogen. J Neural Transm 2003;110:517-536.
44. Newman R, Winans SS. An experimental study of the ventral striatum of the golden hamster. II. Neuronal connections of the olfactory tubercle. J Comp Neurol 1980;191:193-212.
45. Hawkes CH, Del Tredici K, Braak H. Parkinson's disease: a dual hit hypothesis. Neuropathol Appl Neurobiol 2007;33:599-614.
46. Doty RL, Singh A, Tetrude J, et al. Lack of olfactory dysfunction in MPTP-induced parkinsonism. Ann Neurol 1992;32:97-100.
47. Langston JW, Forno LS, Tetrud J, et al. Evidence of active nerve cell degeneration in the substantia nigra of humans years after 1-methyl-4-phenyl-1, 2,3,6-tetrahydropyridine exposure. Ann Neurol 1999;46:598-605.
48. Ross GW, Abbott RD, Petrovitch H, et al. Association of olfactory dysfunction with incidental Lewy bodies. Move Disord. 2006;21:2062-2067.
49. Prediger RDS, Batista LC, Medeiros R, et al. The risk is in the air: Intranasal administration of MPTP to rats reproducing clinical features of Parkinson's disease. Exp Neurol. 2006;202:391-403.
50. Giovanni A, Sieber BA, Heikkila RE, et al. Studies on species sensitivity to the dopaminergic neurotoxin 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine. 1. Systemic administration. J Pharm Exp Therap 1994;270:1000-1007.
51. Giovanni A, Somalla PK, Heikkila RE. Studies on species sensitivity to the dopaminergic neurotoxin 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine. 2. Central administration of 1-methyl-4-phenylpyridinium. J Pharm Exp Therap. 1994;270:1008-1014.
52. Pardo LM, van Duijn CM. In search of genes involved in neurodegenerative disorders. Mutat Res 2005;592:89-101.
53. Arriagada PV, Louis DN, Hedley-Whyte ET, et al. Neurofibrillary tangles and olfactory dysgenesis. Lancet 1991;337:559.
54. Braak H, Braak E. Neuropathological staging of Alzheimer-related changes. Acta Neuropathol 1991;82:239-259.
55. Price JL, Davis PB, Morris JC, et al. The distribution of tangles, plaques and related immunohistochemical markers in healthy aging and Alzheimer's disease. Neurobiol Aging 1991;12:295-312.
56. Mann DMA, Tucker CM, Yates PO. Alzheimer's disease: an olfactory connection? Mech Ageing Dev 1988;42:1-15.
57. Sun TJ, Miller ML, Hastings L. Effects of inhalation of cadmium on the rat olfactory system: behavior and morphology. Neurotoxicol Teratol 1996;18:89-98.
58. Stroop WG, Schaefer DC. Production of encephalitis restricted to the temporal lobes by experimental reactivation of herpes-simplex virus. J Infect Dis 1986;153:721-731.
59. Allam MF, Del Castillo AS, Navajas RF. Parkinson's disease risk factors: genetic, environmental, or both? Neurol Res 2005;27:206-208.
60. Khan NL, Jain S, Lynch JM, et al. Mutations in the gene LRRK2 encoding dardarin (PARK8) cause familial Parkinson's disease: clinical, pathological, olfactory and functional imaging and genetic data. Brain 2005;128:2786-2796.
61. Tolosa E, Wenning G, Poewe W. The diagnosis of Parkinson's disease. Lancet Neurol 2006;5:75-86.
62. Klatka LA, Schiffer RB, Powers JM, et al. Incorrect diagnosis of Alzheimer's disease. A clinicopathologic study. Arch Neurol 1996;53:35-42.
63. Barnett EM, Cassell MD, Perlman S. Two neurotrpic viruses, herpes simplex virus Type 1 and mouse heparitus virus, spread along different neural pathways from the main olfactory bulb. Neuroscience 1993;57:1007-1025.
64. Kalmey JK, Thewissen JG, Dluzen DE. Age-related size reduction of foramina in the cribriform plate. Anat Rec 1998;251:326-329.
65. Nakashima T, Kimmelman CP, Snow JB Jr. Structure of human fetal and adult olfactory neuroepithelium. Arch Otolaryngol 1984;110:641-646.
66. Kurtz P, Schuurman T, Prinz H. Loss of smell leads to dementia in mice: Is Alzheimer's disease a degenerative disorder of the olfactory system? J Protein Chem. 1989;8:448-451.
67. Hall RD, Macrides F. Olfactory bulbectomy impairs the rat's radial-maze behavior. Physiol Behav 1983;30:797-803.
68. Brunjes PC. Lessons from lesions - the effects of olfactory bulbectomy. Chem Senses 1992;17:729-763.
69. Kelly JP, Wrynn AS, Leonard BE. The olfactory bulbectomized rat as a model of depression: An update. Pharmcol. Ther. 1997;74:299-316.
70. Aleksandrova IY, Kuvichkin W, Kashparov IA, et al. Increased level of beta-amyloid in the brain of bulbecromized mice. Biochemistry (Mosc) 2004;69:176-180.
71. Johnson-Wood K, Lee M, Motter R, et al. Amyloid precursor protein processing and A beta42 deposition in a transgenic mouse model of Alzheimer disease. Proc Natl Acad Sci USA 1997;94:1550-1555.
72. Smith DH, Chen XH, Nonaka M, et al. Accumulation of amyloid beta and tau and the formation of neurofilament inclusions following diffuse brain injury in the pig. J Neuropathol Exp Neurol 1999;58:982-992.
73. Meisami E, Manoochehri S. Effects of early bilateral chemical destruction of olfactory receptors on postnatal growth, Mg-ATPase and Na-K-ATPase activity of olfactory and non-olfactory structures of the rat brain. Brain Res 1977;128:170-175.
74. Baker H, Kawano T, Albert V, et al. Olfactory bulb dopamine neurons survive deafferentation-induced loss of tyrosine hydroxylase. Neuroscience 1984;11:605-615.
75. Margolis FL, Roberts N, Ferriero D, et al. Denervation in primary olfactory pathway of mice - biochemical and morphological effects. Brain Res 1974;81:469-483.
76. Yousem DM, Geckle RJ, Bilker WB, et al. Olfactory bulb and tract and temporal lobe volumes. Normative data across decades. Ann N Y Acad Sci 1998;855:546-555.
77. Yousem DM, Geckle RJ, Bilker WB, et al. Posttraumatic smell loss: relationship of psychophysical tests and volumes of the olfactory bulbs and tracts and the temporal lobes. Acad Radiol 1999;6:264-272.
78. Rombaux P, Mouraux A, Bertrand B, et al. Olfactory function and olfactory bulb volume in patients with postinfectious olfactory loss. Laryngoscope 2006;116:436-439.
79. Turetsky BI, Moberg PJ, Yousem DM, et al. Reduced olfactory bulb volume in patients with schizophrenia. Am J Psychiatry 2000;157:828-830.
80. Zhao H, Otaki JM, Firestein S. Adenovirus-mediated gene transfer in olfactory neurons in vivo. J Neurobiol 1996;30:521-530.
81. Mulder W, Pol J, Kimman T, et al. Glycoprotein D-negative Pseudorabies virus can spread transneuronally via direct neuron-to-neuron transmission in its natural host, the pig, but not after additional inactivation of gE or gI. J Virol 1996;70:2191-2200.
82. Morales JA, Herzog S, Kompter C, et al. Axonal transport of Borna disease virus along olfactory pathways in spontaneously and experimentally infected rats. Med Microbiol Immunol 1988;177:51-68.
83. Diel DG, Almeida SR, Brum MCS, et al. Acute and latent infection by bovine herpesvirus type 5 in experimentally infected goats. Vet Microbiol 2007;121:257-267.
84. Rudd PA, Cattaneo R, von Messling V. Canine distemper virus uses both the anterograde and the hematogenous pathway for neuroinvasion. J Virol 2006;80:9361-9370.
85. Roberts JA. Histopathogenesis of mousepox. 1. Respiratory infection. Br J Exp Pathol 1962;43:451-461.
86. Narita M, Uchimura A, Kawanabe M, et al. Invasion and spread of equine herpesvirus 9 in the olfactory pathway of pigs after intranasal inoculation. J Comp Pathol 2001;124:265-272.
87. Esiri MM, Tomlinson AH. Herpes-simplex encephalitis - immunohistological demonstration of spread of virus via olfactory and trigeminal pathways after infection of facial skin in mice. J Neurol Sci 1984;64:213-217.
88. Stroop WG, Rock DL, Fraser NW. Localization of herpes simplex virus in the trigeminal and olfactory systems of the mouse central nervous system during acute and latent infections by in situ hybridization. Lab Invest 1984;51:27-38.
89. Aronsson F, Robertson B, Ljunggren HG, et al. Invasion and persistence of the neuroadapted influenza virus A/WSN/33 in the mouse olfactory system. Viral Immunol 2003;16:415-423.
90. Lafay F, Coulon P, Astic L, et al. Spread of the CVS strain of rabies virus and of the avirulent mutant AvO1 along the olfactory pathways of the mouse after intranasal inoculation. Virology 1991;183:320-330.
91. Mori I, Komatsu T, Takeuchi K, et al. Parainfluenza virus type 1 infects olfactory neurons and establishes long-term persistence in the nerve tissue. J Gen Virol 1995;76:1251-1254.
92. Oliver KR, Fazakerley JK. Transneuronal spread of Semliki Forest virus in the developing mouse olfactory system is determined by neuronal maturity. Neuroscience 1998;82:867-877.
93. Ryzhikov AB, Ryabchikova EI, Sergeev AN, et al. Spread of Venezuelan equine encephalitis virus in mice olfactory tract. Arch Virol 1995;140:2243-2254.
94. Reiss CS, Plakhov IV, Komatsu T. Viral replication in olfactory receptor neurons and entry into the olfactory bulb and brain. Ann N Y Acad Sci 1998;855:751-761.
95. Perl DP, Good PF. Uptake of aluminium into central nervous system along nasal-olfactory pathways. Lancet 1987;1:1028.
96. Hayek R, Waite PME. The olfactory pathway as a possible route for aluminum entry to the brain. J Neurochem 1991;57:S113.
97. Zatta P, Favarato M, Nicolini M. Deposition of aluminum in brain-tissues of rats exposed to inhalation of aluminum acetylacetonate. Neuroreport 1993;4:1119-1122.
98. Tallkvist J, Persson E, Henriksson J, et al. Cadmium-metallothionein interactions in the olfactory pathways of rats and pikes. Toxicol Sci 2002;67:108-113.
99. Gottofrey J, Tjalve H. Axonal transport of cadmium in the olfactory nerve of the pike. Pharmacol Toxicol 1991;69:242-252.
100. Tjalve H, Henriksson J. Uptake of metals in the brain via olfactory pathways. Neurotoxicology 1999;20:181-195.
101. Hastings L, Evans J. Transaxonal transport of cadmium in the olfactory system. Chem Senses 1988;13:696.
102. Persson E, Henriksson J, Tjalve H. Uptake of cobalt from the nasal mucosa into the brain via olfactory pathways in rats. Toxicol Lett 2003;145:19-27.
103. Bazer GT, Ebbesson SOE, Reynolds JB, et al. A Cobalt-Lysine Study of Primary Olfactory Projections in King Salmon Fry (Oncorhynchus-Tshawytscha Walbaum). Cell Tissue Res 1987;248:499-503.
104. De Lorenzo AJD. The olfactory neuron and the blood brain barrier. In: Wolstenholme GEW, Knight J, eds. Taste and smell in vertebrates. London: Churchill Livingstone, 1970:151-171.
105. Czerniawska A. Experimental investigations on penetration of Au-198 from nasal mucous membrane into cerebrospinal fluid. Acta Otolaryngol (Stockh) 1970;70:58-61.
106. Wang B, Feng WY, Wang M, et al. Transport of intranasally instilled fine Fe2O3 particles into the brain: microdistribution, chemical states, and histopathological observation. Biol Trace Elem Res 2007;118:233-243.
107. Tjalve H, Mejare C, Borg-Neczak K. Uptake and transport of manganese in primary and secondary olfactory neurones in pike. Pharm Toxicol 1995;77:23-31.
108. Henriksson J, Tallkvist J, Tjalve H. Transport of manganese via the olfactory pathway in rats: dosage dependency of the uptake and subcellular distribution of the metal in the olfactory epithelium and the brain. Toxicol Appl Pharmacol 1999;156:119-128.
109. Borg-Neczak K, Tjalve H. Uptake of 203Hg2+ in the olfactory system in pike. Toxicol Lett 1996;84:107-112.
110. Tallkvist J, Henriksson J, d'Argy R, et al. Transport and subcellular distribution of nickel in the olfactory system of pikes and rats. Toxicol Sci 1998;43:196-203.
111. Persson E, Henriksson J, Tallkvist J, et al. Transport and subcellular distribution of intranasally administered zinc in the olfacrory system of rats and pikes. Toxicology 2003;191:97-108.